Navigation Links
CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue
Date:3/16/2010

ATLANTA, March 16 /PRNewswire/ -- CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that investigators from the Mercer University School of Medicine, Emory University and CorMatrix Cardiovascular, Inc. demonstrated that an injectable emulsion of the company's ECM Technology enhances angiogenesis (new blood vessel growth), improves cardiac function, and increases the recruitment of bone-marrow derived (c-kit positive) stem cells, myofibroblasts, and macrophages in a rat model of myocardial infarction (heart attack).  The research, published in the March 23 print version of the Journal of the American College of Cardiology, was posted today on the Journal's website (http://content.onlinejacc.org).

"What is significant about our approach, compared to other attempts at developing stem-cell therapies for treating damaged heart tissue, is that we're able to avoid the pitfalls associated with trying to manipulate the individual cell types involved by allowing the ECM to naturally support the individual phases of tissue remodeling," said Robert G. Matheny, MD, Chief Scientific Officer of CorMatrix, and a co-author on the study. "Results from this study
'/>"/>

SOURCE CorMatrix Cardiovascular, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
(Date:7/2/2015)... TX and VANCOUVER , July ... "Company") (TSX-V: EPI) announced today that its common shares have ... Market ("NASDAQ") under the symbol "EPIX". ESSA will ... will retain its listing on the TSX Venture Exchange under ... listing of the common shares on the NASDAQ, each of ...
(Date:7/2/2015)... England , July 2, 2015 ... known as ,Friendly Aedes aegypti , , ... Juazeiro, Brazil by 95%, well ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal ... a trial of Oxitec,s genetically engineered mosquitoes. The results ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
(Date:7/3/2015)... ... 03, 2015 , ... On June 30th SEO authority and ... system called "Page One Engine" . The program, which has been hailed ... from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an ...
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... on June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy ... injured bicyclists and practical points of investigating these types of cases. , Each ...
(Date:7/3/2015)... ... , ... Talcum powder attorneys representing clients in national lawsuits announce the launch ... website. Just as the previous version did, the new website will serve as a ... ovarian cancer warning information. The site is routinely updated with news articles on talcum ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3
... 21 Barr Pharmaceuticals, Inc. (NYSE: BRL ) ... to them relating to the acquisition of Barr by Teva ... , "Today,s vote demonstrated the ... Bruce L. Downey, Barr,s Chairman and CEO. "We are pleased ...
... a statewide survey, 33 physicians credentialed to practice at the Texas ... Texas Monthly in its 2008 annual listing of " ... year, the publishers of Texas Monthly work with Key ... the state of Texas to ask, "If you needed medical care, ...
... Nov. 21 Innerscope Research(TM), a revolutionary,biometric media ... the appointment of three executives who will strengthen ... , The ... of experience,include Geoffrey Gill as Chief Financial Officer ...
... Three Minnesotans who successfully,quit smoking will receive big prizes during ... 24 at the Xcel Energy Center. The winners,were participants in ... QUITPLAN(R) Services. , The ... runners-up,will get $1,000 gift cards from Gander Mountain. , ...
... needed less pain meds, study found , , FRIDAY, Nov. ... the amount of pain-killing medication requested by women during ... expectant mothers. , Half the women were assigned ... during their pregnancy, while the other half acted as ...
... cardiovascular disease are not given adequate drug therapy. This is ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... German results of this prospective, one-year survey. , 512 doctors ... patients in all, of whom 89.2% suffered from one or ...
Cached Medicine News:Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:Aquarobics May Help Ease Labor 2
... The OTF5000 represents the new style ... long-established and reliable OTF/AS cryostat, the ... systems in the ever-reliable and powerful ... options plus money-saving package deals makes ...
... Leica TP1020 product family are semi-enclosed tissue ... combination of approved technology with modern and ... maximum safety for tissues at all stages ... based on proven precision mechanics in conjunction ...
... A unique sliding microtome with ... during return travel. Maintenance-free precision cross ... specimens and specialty applications in biological, ... up to 155 x 90 mm ...
... face-lifted Leica RM2125 microtome comes in two ... Leica RM2125 RT. All RM2125 versions are ... debris entering the precision micrometer feeding system. ... two-step trimming function and specimen retraction as ...
Medicine Products: